Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Global surveillance of trends in cancer survival 2000–14 (Concord-3)

Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Bibliographic Data

ID23314337
AuthorsClaudia Allemani (0000-0003-4871-3766, London School of Hygiene & Tropical Medicine, corresponding author), Tomohiro Matsuda (0000-0002-7311-1233), V Di Carlo (0000-0001-7244-9526, London School of Hygiene & Tropical Medicine), Rhea Harewood (0000-0003-4446-2138, London School of Hygiene & Tropical Medicine), Melissa Matz (0000-0003-0132-1108, London School of Hygiene & Tropical Medicine), Maja Nikšić (0000-0002-3101-4953, London School of Hygiene & Tropical Medicine), Audrey Bonaventure (0000-0001-6665-8145, London School of Hygiene & Tropical Medicine), Mikhail Yu Valkov (0000-0003-3230-9638, Northern State Medical University), Mikhail Valkov, Christopher J Johnson (0000-0003-0730-0877), Jacques Estève (Lyon 1 Université), Olufemi J Ogunbiyi (0000-0002-8748-2879), Gláucia Alves E Silva (0000-0001-8734-2799, Universidade do Estado do Rio de Janeiro), Gulnar Azevedo E Silva, Wanqing Chen (0000-0002-1159-1884), Wan-qing Chen, Sultan Eser (0000-0003-4427-4540, Balıkesir University), Gerda Engholm (0000-0002-5337-6234, Danish Cancer Society), Charles Stiller (0000-0002-3006-7869, Public Health England), Charles A Stiller, Alain Monnereau (0000-0002-5056-1397, Institut Bergonié), Ryan Woods (0000-0002-9520-2128, BC Cancer Agency), Ryan R Woods, Otto Visser (0000-0003-1496-1817, Netherlands Comprehensive Cancer Organisation), Gek Hsiang Lim (0000-0002-8298-4618, Health Promotion Board), Joanne F Aitken (0000-0001-6859-2186, Cancer Council Queensland), Joanne Aitken, Hannah K Weir (0000-0001-6568-9708, Centers for Disease Control and Prevention), Michel P Coleman (0000-0001-8940-3807, London School of Hygiene & Tropical Medicine), S Bouzbid (0000-0002-7253-551X, Health Promotion Board), M Hamdi-Chérif (London School of Hygiene & Tropical Medicine), Zoubida Zaidi (0000-0003-3378-4799, Universidade do Estado do Rio de Janeiro), Kaouel Meguenni, D Regagba, Siné Bayo (0009-0000-0673-2761, Health Promotion Board), T Cheick Bougadari (Cancer Council Queensland), S S Manraj (Netherlands Comprehensive Cancer Organisation), Karima Bendahhou, A Fabowale, Debbie Bradshaw (0000-0002-3588-2184), Nontuthuzelo Somdyala (0000-0001-6564-8754), N I M Somdyala, I Kumcher, Florencia Moreno (0000-0001-6181-5025, London School of Hygiene & Tropical Medicine), G H Calabrano (Danish Cancer Society), S B Espinola, B Carballo Quintero (London School of Hygiene & Tropical Medicine), R Fita, M C Diumenjo, W D Laspada, S G Ibañez, Cinthia Almeida Lima (0009-0002-1019-0584), P C F De Souza, K Del Pino, C Laporte, Maria Paula Curado (0000-0001-8172-2483), José Carlos De Oliveira (0000-0002-0415-4926), C L A Veneziano (London School of Hygiene & Tropical Medicine), Donaldo Botelho Veneziano (0000-0001-9677-2133), M R D O Latorre, Luana Fiengo Tanaka (0000-0002-2086-7491), Marise Souto Rebelo (Health Promotion Board), M O Santos (Institut Bergonié), J C Galaz, M Aparicio Aravena (London School of Hygiene & Tropical Medicine), J Sanhueza Monsalve (Cancer Council Queensland), D A Herrmann, S Vargas, S Torres Vargas (Health Promotion Board), V M Herrera (0000-0002-2393-9024), Veronica Herrera (0000-0002-6295-1640, Northern State Medical University), Claudia Uribe (0000-0001-7290-6096), C J Uribe, Luis Eduardo Bravo (0000-0002-9708-0312, London School of Hygiene & Tropical Medicine), Luz Stella García (0000-0002-8108-1855), Nelson Enrique Arias-Ortiz (0000-0001-5093-3384, Cancer Council Queensland), D Morantes, D M Jurado, Daniel Jurado (0000-0003-0628-0253, London School of Hygiene & Tropical Medicine), María Clara Yépez Chamorro (0000-0002-3482-5786), Sandra Delgado (0000-0003-0771-9264, Health Promotion Board), M Ramírez (0000-0001-7041-4346), Y H Galán Alvarez, Priscila Torres (0000-0002-3087-3115), F Martínez-Reyes (London School of Hygiene & Tropical Medicine), L Jaramillo (London School of Hygiene & Tropical Medicine), R Quinto, J Castillo (0009-0006-5346-3684, Cancer Council Queensland), M Mendoza (0000-0002-8614-3808, London School of Hygiene & Tropical Medicine), Patricia Cueva, J G Yépez, Bernard Bhakkan (0000-0002-0504-7102, London School of Hygiene & Tropical Medicine), Jacqueline Deloumeaux (0000-0001-7841-3313, Cancer Council Queensland), Clarisse Joachim (0000-0002-2967-7205), Jonathan Macni (0000-0003-0098-2078, Cancer Council Queensland), R Carrillo (0009-0000-7412-5699), J Shalkow Klincovstein (Cancer Council Queensland), Rebeca Rivera-Gómez (0009-0001-2841-012X), R Rivera Gomez, Ebert Poquioma (London School of Hygiene & Tropical Medicine), G Tortolero-Luna, Guillermo Tortolero‐Luna (0000-0002-2792-0259), Diego Zavala, R Alonso, Enrique Barrios (0000-0001-6608-8605, London School of Hygiene & Tropical Medicine), Angela Eckstrand, C Nikiforuk, Glen Noonan, D Turner (0000-0001-5603-8145), E Kumar (0000-0001-7888-350X), B Zhang (0000-0002-4591-0361, London School of Hygiene & Tropical Medicine), F R McCrate, S Ryan (0000-0002-1743-1021, BC Cancer Agency), M Macintyre (0000-0002-9917-4590), N Saint-Jacques, D E Nishri, C A McClure, K A Vriends, S Kozie, H Stuart-Panko, T Freeman (0000-0002-9317-811X), J T George, J T Brockhouse, D K O'Brien, A Holt, L Almon, S Kwong, C Morris (0000-0001-6826-8511), R Rycroft, L Mueller, C E Phillips, H Brown (0000-0003-2210-9624), B Cromartie, A G Schwartz, F Vigneau, G M Levin, B Wohler, R Bayakly, K C Ward, S L Gomez, M McKinley, R Cress, M D Green, K Miyagi, L P Ruppert, C F Lynch, B Huang (0009-0006-7579-5890), T C Tucker (0000-0002-5993-484X), D Deapen, L Liu (0000-0001-6283-5220), M C Hsieh, X C Wu, M Schwenn, S T Gershman, R C Knowlton, G Alverson, G E Copeland, S Bushhouse, D B Rogers, J Jackson-Thompson, D Lemons, H J Zimmerman, M Hood, J Roberts-Johnson, J R Rees, B Riddle, K S Pawlish, A Stroup, C Key, C Wiggins, A R Kahn, M J Schymura, S Radhakrishnan (0009-0006-4648-8672), C Rao, L K Giljahn, R M Slocumb, R E Espinoza, F Khan (0000-0002-5638-4299), K G Aird, T Beran, J J Rubertone, S J Slack, L Garcia (0009-0005-0311-3849), D L Rousseau, T A Janes, S M Schwartz, S W Bolick, D M Hurley (0000-0003-1052-1494), M A Whiteside, P Miller-Gianturco, M A Williams (0000-0003-3802-7914), K Herget, C Sweeney (0000-0002-4943-9423), A T Johnson (0000-0002-9848-2727), M B Keitheri Cheteri, P Migliore Santiago, S E Blankenship, S Farley, R Borchers, R Malicki, J R Espinoza, J Grandpre, R Wilson (0009-0007-6069-2423), B K Edwards, A Mariotto, Y Lei (0009-0008-9057-6527), N Wang (0000-0002-2955-7588), J S Chen (0000-0003-2334-8264), Y Zhou (0000-0002-3658-1308), Y T He, G H Song, X P Gu, D Mei, H J Mu, H M Ge, T H Wu, Y Y Li (0000-0003-4140-504X), D L Zhao, F Jin, J H Zhang (0000-0002-8995-899X), F D Zhu, Q Junhua, Y L Yang, C X Jiang, W Biao, J Wang (0000-0001-6484-4040), Q L Li, H Yi (0000-0003-4724-5235), Xueqi Zhou (0000-0001-9864-3001), J Dong (0009-0001-0779-0725), Weiya Li (0000-0001-7040-8472), F X Fu, S Z Liu (0009-0007-5055-2590), J G Chen, J Zhu (0000-0001-8729-511X), Y H Li (0009-0003-8615-6080), Y Q Lu, M Fan, S Q Huang, G P Guo, H Zhaolai, K Wei (0000-0001-5556-9534), H Zeng (0000-0001-8204-0994), A V Demetriou, W K Mang, K C Ngan, A C Kataki, M Krishnatreya, P A Jayalekshmi, P Sebastian, A Nandakumar (0000-0002-0976-9313), R Malekzadeh, G Roshandel, L Keinan-Boker, B G Silverman, H Ito, H Nakagawa, M Sato (0000-0001-6516-7483), F Tobori, I Nakata, N Teramoto, M Hattori (0000-0002-1317-1330), Y Kaizaki, F Moki, H Sugiyama (0000-0003-2536-0865), M Utada, M Nishimura, K YOSHIDA (0000-0002-4434-4409), K Kurosawa, Y Nemoto, H Narimatsu, M SAKAGUCHI, S Kanemura, M Naito, R Narisawa, I Miyashiro, K Nakata, S Sato (0009-0000-7413-1618), M Yoshii, I Oki, N Fukushima, A Shibata, K Iwasa, C Ono, O Nimri, K W Jung, Y J Won, E Alawadhi, A Elbasmi, A Ab Manan, F Adam, E Sanjaajmats, U Tudev, C Ochir, A M Al Khater, M M El Mistiri, Y Y Teo, C J Chiang, W C Lee, R Buasom, S Sangrajrang, S Kamsa-ard, S Wiangnon, K Daoprasert, D Pongnikorn, A Leklob, S Sangkitipaiboon, S L Geater, H Sriplung, O Ceylan, I Kög, O Dirican, T Köse, T Gurbuz, F E Karaşahin, D Turhan, U Aktaş, Y Halat, C I Yakut, M Altinisik, Y Cavusoglu, A Türkköylü, N Üçüncü, M Hackl, A A Zborovskaya, O V Aleinikova, K Henau, L Van Eycken, Z Valerianova, M R Yordanova, M Šekerija, L Dušek, M Zvolský, H Storm, K Innos, M Mägi, N Malila, K Seppä, J Jégu, M Velten, E Cornet, X Troussard, A M Bouvier, A V Guizard, V Bouvier, G Launoy, P Arveux, M Maynadié, M Mounier, A S Woronoff, M Daoulas, M Robaszkiewicz, J Clavel, S Goujon, B Lacour, I Baldi, C Pouchieu, B Amadeo, G Coureau, S Orazio, P M Preux, F Rharbaoui, E Marrer, B Tretarre, M Colonna, P Delafosse, K Ligier, S Plouvier, A Cowppli-Bony, F Molinié, S Bara, O Ganry, B Lapôtre-Ledoux, P Grosclaude, N Bossard, Z Uhry, F Bray, M Piñeros, R Stabenow, H Wilsdorf-Köhler, A Eberle, S Luttmann, I Löhden, A L Nennecke, J Kieschke, E Sirri, K Emrich, S R Zeissig, B Holleczek, N Eisemann, A Katalinic, R A Asquez, V Kumar (0000-0003-1381-820X), E Petridou, E J Ólafsdóttir, L Tryggvadóttir, K Clough-Gorr, P M Walsh, H Sundseth, G Mazzoleni, F Vittadello, E Coviello, F Cuccaro, R Galasso, G Sampietro, A Giacomin, M Magoni, A Ardizzone, A D'Argenzio, M Castaing, G Grosso, A M Lavecchia, A Sutera Sardo, G Gola, L Gatti, P Ricci, S Ferretti, D Serraino, A Zucchetto, M V Celesia, R A Filiberti, F Pannozzo, A Melcarne, F Quarta, A G Russo, G Carrozzi, C Cirilli, L Cavalieri d'Oro, M Rognoni, M Fusco, M F Vitale, M Usala, R Cusimano, W Mazzucco, M Michiara, P Sgargi, L Boschetti, E Borciani, P Seghini, M M Maule, F Merletti, R Tumino, P Mancuso, M Vicentini, T Cassetti, R Sassatelli (0000-0003-4240-9691), F Falcini, S Giorgetti, A L Caiazzo, R Cavallo, R Cesaraccio, D R Pirino, M L Contrino, F Tisano, A C Fanetti, S Maspero, S Carone, A Mincuzzi, G Candela, T Scuderi, M A Gentilini, S Piffer, S Rosso, A Barchielli, A Caldarella, F Bianconi, F Stracci, P Contiero, G Tagliabue, M Rugge, M Zorzi, S Beggiato, A Brustolin, F Berrino, G Gatta, M Sant, C Buzzoni, L Mangone, R Capocaccia, R De Angelis, R Zanetti, A Maurina, S Pildava, N Lipunova, I Vincerževskiené, D Agius, N Calleja, S Siesling, S Larønningen, B Møller, A Dyzmann-Sroka, M Trojanowski, S Góźdź, R Mężyk, T Mierzwa, L Molong, J Rachtan, S Szewczyk, J Błaszczyk, K Kępska, B Kościańska, K Tarocińska, M Zwierko, K Drosik, K M Maksimowicz, E Purwin-Porowska, E Reca, J Wójcik-Tomaszewska, A Tukiendorf, M Grądalska-Lampart, A U Radziszewska, A Gos, M Talerczyk, M Wyborska, J A Didkowska, U Wojciechowska, M Bielska-Lasota, G Forjaz de Lacerda, R A Rego, J Bastos, M A Silva (0000-0001-5333-3528), L Antunes, J Laranja Pontes, A Mayer-da-Silva, A Miranda (0000-0002-3261-4344), L M Blaga, D Coza, L Gusenkova, O Lazarevich, O Prudnikova, D M Vjushkov, A G Egorova, A E Orlov, L A Kudyakov, L V Pikalova (0000-0003-1453-2254), J Adamcik, C Safaei Diba, M Primic-Žakelj, V Zadnik, N Larrañaga, A Lopez de Munain, A A Herrera, R Redondas, R Marcos-Gragera, M L Vilardell Gil, E MOLINA (0000-0002-4163-4646), M J Sánchez Pérez, P Franch Sureda, M Ramos Montserrat, M D Chirlaque, C Navarro (0000-0002-3127-7358), E E Ardanaz, M M Guevara, R Fernández-Delgado, R Peris-Bonet, M Carulla, J Galceran, C Alberich, M Vicente-Raneda, S Khan (0000-0002-0602-8739), D Pettersson, P Dickman, I Avelina, K Staehelin, B Camey, C Bouchardy, R Schaffar, H Frick, C Herrmann (0000-0001-9349-8917), J L Bulliard, M Maspoli-Conconi, C E Kuehni, S M Redmond, A Bordoni, L Ortelli, A Chiolero, I Konzelmann, K L Matthes, S Rohrmann, J Broggio, J Rashbass, D Fitzpatrick (0000-0001-7326-6166), A Gavin, D I Clark, A J Deas, D W Huws, C White (0000-0003-4710-4723), L Montel, B Rachet, A D Turculet, R Stephens, E Chalker, H Phung, R Walton (0009-0007-0662-9861), H You (0000-0003-2760-5328), S Guthridge, F Johnson (0000-0001-5708-1807), P Gordon, K D'Onise, K Priest, B C Stokes, A venn, H Farrugia, V Thursfield, J Dowling, D Currow, J Hendrix, C Lewis (0000-0001-8137-4802)
Year2018
Volume391
Issue10125
Pages1023-1075
Publication date2018-03-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueThe Lancet (JOURNAL)
Journal identifiersISSN: 0099-5355 • E-ISSN: 0140-6736
PublisherElsevier BV (PUBLISHER)
DOI10.1016/s0140-6736(17)33326-3
PMID29395269
OpenAlexW2787553551
LanguageEN
Citations received128
References cited72

BACKGROUND: In 2015, the second cycle of the CONCORD programme established global surveillance of cancer survival as a metric of the effectiveness of health systems and to inform global policy on cancer control. CONCORD-3 updates the worldwide surveillance of cancer survival to 2014. METHODS: CONCORD-3 includes individual records for 37·5 million patients diagnosed with cancer during the 15-year period 2000-14. Data were provided by 322 population-based cancer registries in 71 countries and territories, 47 of which provided data with 100% population coverage. The study includes 18 cancers or groups of cancers: oesophagus, stomach, colon, rectum, liver, pancreas, lung, breast (women), cervix, ovary, prostate, and melanoma of the skin in adults, and brain tumours, leukaemias, and lymphomas in both adults and children. Standardised quality control procedures were applied; errors were rectified by the registry concerned. We estimated 5-year net survival. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: For most cancers, 5-year net survival remains among the highest in the world in the USA and Canada, in Australia and New Zealand, and in Finland, Iceland, Norway, and Sweden. For many cancers, Denmark is closing the survival gap with the other Nordic countries. Survival trends are generally increasing, even for some of the more lethal cancers: in some countries, survival has increased by up to 5% for cancers of the liver, pancreas, and lung. For women diagnosed during 2010-14, 5-year survival for breast cancer is now 89·5% in Australia and 90·2% in the USA, but international differences remain very wide, with levels as low as 66·1% in India. For gastrointestinal cancers, the highest levels of 5-year survival are seen in southeast Asia: in South Korea for cancers of the stomach (68·9%), colon (71·8%), and rectum (71·1%); in Japan for oesophageal cancer (36·0%); and in Taiwan for liver cancer (27·9%). By contrast, in the same world region, survival is generally lower than elsewhere for melanoma of the skin (59·9% in South Korea, 52·1% in Taiwan, and 49·6% in China), and for both lymphoid malignancies (52·5%, 50·5%, and 38·3%) and myeloid malignancies (45·9%, 33·4%, and 24·8%). For children diagnosed during 2010-14, 5-year survival for acute lymphoblastic leukaemia ranged from 49·8% in Ecuador to 95·2% in Finland. 5-year survival from brain tumours in children is higher than for adults but the global range is very wide (from 28·9% in Brazil to nearly 80% in Sweden and Denmark). INTERPRETATION: The CONCORD programme enables timely comparisons of the overall effectiveness of health systems in providing care for 18 cancers that collectively represent 75% of all cancers diagnosed worldwide every year. It contributes to the evidence base for global policy on cancer control. Since 2017, the Organisation for Economic Co-operation and Development has used findings from the CONCORD programme as the official benchmark of cancer survival, among their indicators of the quality of health care in 48 countries worldwide. Governments must recognise population-based cancer registries as key policy tools that can be used to evaluate both the impact of cancer prevention strategies and the effectiveness of health systems for all patients diagnosed with cancer. FUNDING: American Cancer Society; Centers for Disease Control and Prevention; Swiss Re; Swiss Cancer Research foundation; Swiss Cancer League; Institut National du Cancer; La Ligue Contre le Cancer; Rossy Family Foundation; US National Cancer Institute; and the Susan G Komen Foundation.

Cancer · Cancer registry · Environmental health · Population · Relative survival · Advances in Oncology and Radiotherapy · Demography · Global Cancer Incidence and Screening · Internal Medicine · Medicine · Multiple and Secondary Primary Cancers · Oncology

  • ‘You've Given Me My Voice’—Enhancing Engagement in Exercise Oncology Research

    Open Access•Matthew Beggs, Joanne Reid et al.•Health Expectations•2026

  • Analysis of Status and Influencing Factors of Psychology Resilience Level in Cancer Patients Undergoing Radiotherapy and Chemotherapy

    Open Access•Liya Xu, Lida C Landicho et al.•Journal of Psychological Research•2023

  • Estudo de aceitabilidade das intervenções psicológicas via telefone para sobreviventes de cancro dos Açores

    Open Access•Marina Sousa, Helena Moreira et al.•Revista Psicologia Diversidade e…•2021

  • Development of a Digital Dictionary for Measuring Arabic Language Education Students Retention

    Open Access•Akhyar Hanif, Deswita Deswita et al.•MIGRATION LETTERS•2023

  • Breast Cancer in Western Kazakhstan

    Open Access•Marzhan A Aitmagambetova, M Aitmagambetova et al.•Ekologiya Cheloveka (Human Ecology•2021

  • Incidencia del cáncer de cuello uterino y sobrevida de pacientes en Manizales, Colombia, 2008-2012

    Open Access•Cristian Camilo Benítez-Restrepo, Nelson Enrique Arias-Ortiz et al.•Revista Peruana de Medicina…•2020

  • Validation of Death and Dying Distress Scale-Chinese Version and Prevalence of Death Anxiety Among Patients With Advanced Cancer

    Open Access•Lili Tang, Yening Zhang et al.•Frontiers in Psychiatry•2021

  • Analysis of Perceptions, Preferences, and Participation Intention of Urban Forest Healing Program among Cancer Survivors

    Open Access•Eun Young Park, Min Kyung Song et al.•International Journal of…•2023

  • Determinants of delay from cancer diagnosis to treatment initiation in a cohort of brazilian women with breast cancer

    Open Access•Giselle Coutinho Medeiros, Luiz Claudio Santos Thuler et al.•Health & Social Care in the…•2021

  • Comparison of factors associated with leukemia and lymphoma mortality in Brazil

    Open Access•Mariana Dos Santos Gouveia, Jessica Keyla Matos Batista et al.•Cadernos de Saude Publica•2020

  • Desigualdades sociais em câncer no sexo masculino em uma metrópole da região Sudeste do Brasil

    Open Access•Millene Da Cruz Ferreira, Ivan Arroyave et al.•Revista de Saúde Pública•2023

  • Breast imaging hindered during covid-19 pandemic, in Brazil

    Open Access•Jordana de Faria Bessa•Revista de Saúde Pública•2021

  • Trends and projections of Non-Hodgkin lymphoma burden (1990–2040)

    Open Access•Shengqiang Wang, Hongfeng Zhou et al.•BMC Public Health•2025

  • Labour market participation after sickness absence due to cancer

    Open Access•Amaya Ayala‐García, Amaya Ayala-Garcia et al.•BMC Public Health•2023

  • Psychometric development of a new body image scale for breast cancer survivors

    Erika Biederman, Andrea A Cohee et al.•Health Care For Women International•2019

  • Beating Cancer Inequalities in the EU

    OECD OECD•Beating Cancer Inequalities in…•2024

  • Global cancer statistics 2022

    Open Access•Francesca Bray, Mathieu Laversanne et al.•CA: A Cancer Journal for Clinicians•2024

  • Estimates of incidence and mortality of cervical cancer in 2018

    Open Access•Marc Arbyn, Elizabeth Weiderpa et al.•The Lancet Global Health•2020

  • Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019

    Open Access•R Lozano, Nancy Fullman et al.•The Lancet•2020

  • Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019

    Open Access•Global Burden of Disease Cancer Collaboration, Jonathan Kocarnik et al.•JAMA Oncology•2022

  • High-quality health systems in the Sustainable Development Goals era

    Open Access•Margaret E Kruk, Anna D Gage et al.•The Lancet Global Health•2018

  • Global Cancer Statistics 2020

    Open Access•Hyuna Sung, Adalberto M Filho et al.•CA: A Cancer Journal for Clinicians•2021

  • Cross-sector co-creation of a community-based physical activity program for breast cancer survivors in Colombia

    Open Access•Maria A Rubio, Daniela Mosquera et al.•Health Promotion International•2022

  • Impact of Covid-19 in Patients with Lung Cancer

    Open Access•Damian Mojsak, Michał Dębczyński et al.•International Journal of…•2023

  • Health litigation and cancer survival in patients treated in the public health system in a large Brazilian city, 2014–2019

    Open Access•Mônica S Monteiro De Castro, Gibson Dall''Orto Muniz Da Silva et al.•BMC Public Health•2023

  • Effect of a 12-Week Online Walking Intervention on Health and Quality of Life in Cancer Survivors

    Open Access•Lauren J Frensham, Gaynor Parfitt et al.•International Journal of…•2018

  • Do We Have a Knowledge Gap with Our Patients?—On the Problems of Knowledge Transfer and the Implications at the End of Life

    Open Access•Nils Heuser, Hendrik Heers et al.•International Journal of…•2025

  • Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up

    Open Access•Vitor Duarte, Natália Araújo et al.•International Journal of…•2022

  • Dementia is the second most feared condition among Australian health service consumers

    Open Access•Rochelle Watson, Rob Sanson-Fisher et al.•BMC Public Health•2023

  • Significantly reduced incidence and improved survival from prostate cancer over 25 years

    Open Access•Bernat Carles Serdà-Ferrer, Arantza Sanvisens et al.•BMC Public Health•2023

  • Media Exposure, Cancer Beliefs, and Cancer-Related Information-Seeking or Avoidance Behavior Patterns in China

    Open Access•Rui He, Yungeng Li•International Journal of…•2021

  • Application of the ‘online assessment + Fobt at home’ to improve participation and the efficacy of opportunistic screening for colorectal cancer

    Open Access•Xudong Peng, Gang Tang et al.•BMC Public Health•2023

  • Management, Survival, and Costs of Pancreatic Cancer

    Open Access•Laura Guarga, Noelia Paco et al.•International Journal of…•2023

  • Observational Study on Actual Cancer Screening Participation and Outcomes Among Patients with Lung Cancer Based on Linkage of Cancer Registry and Kyoto City Integrated Database Data from 2014 to 2018

    Open Access•Tomonari Shimamoto, Yukiko Tateyama et al.•International Journal of…•2025

  • Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain

    Open Access•Juan José Montaño Moreno, Antoni Barceló et al.•International Journal of…•2021

  • Childhood and Adolescence Cancers in the Palermo Province (Southern Italy)

    Open Access•Walter Mazzucco, Rosanna Cusimano et al.•International Journal of…•2018

  • Mortality and Years of Life Lost Due to Brain and Other Central Nervous System Cancer in Wuhan, China, from 2010 to 2019

    Open Access•Jiahao Chen, Yan Liu et al.•International Journal of…•2023

  • Temporal Trends in the Completeness of Epidemiological Variables in a Hospital-Based Cancer Registry of a Pediatric Oncology Center in Brazil

    Open Access•Jonathan Grassi, Raphael Manhães Pessanha et al.•International Journal of…•2024

  • Implementation and maintenance of breast cancer screening among Chinese rural women

    Open Access•Huijiao Yan, Qiankun Wang et al.•BMC Public Health•2025

  • Long-Term Influence of the Practice of Physical Activity on the Self-Perceived Quality of Life of Women with Breast Cancer

    Open Access•José Luís García-Soidán, Ignacio Pérez-Ribao et al.•International Journal of…•2020

  • Survival and Characteristics of Bladder Cancer

    Open Access•Mohd Nasrullah Nik Ab Kadir, Suhaily Mohd Hairon et al.•International Journal of…•2021

  • Population-Based Study on Cancer Incidence in Pharmacist

    Open Access•Ya-Wen Lin, Che-Huei Lin et al.•International Journal of…•2021

  • The Effect of Serum Leptin Concentration and Leptin Receptor Expression on Colorectal Cancer

    Open Access•Sylwia Chludzińska-Kasperuk, Jolanta Lewko et al.•International Journal of…•2023

  • Trend in premature mortality from four major NCDs in Nanjing, China, 2007–2018’

    Open Access•Huafeng Yang, Yali Fu et al.•BMC Public Health•2021

  • Comparing the Therapeutic Efficacies of Lung Cancer

    Open Access•Chuan‐Hsin Chang, Chuan-Hsin Chang et al.•International Journal of…•2022

  • Increasing access to fertility preservation for women with breast cancer

    Open Access•Maria Claudia Addamiano, Camille Joannès et al.•BMC Public Health•2024

  • Global comparison of cancer outcomes

    Open Access•Cheuk‐Wai Choi, Horace C W Choi et al.•BMC Public Health•2019

  • Māori perspectives on a potential low dose CT lung cancer screening programme in Aotearoa New Zealand

    Open Access•Tayla Schaapveld, Sarah Colhoun et al.•BMC Public Health•2026

  • Work-Related Factors and Lung Cancer Survival

    Open Access•Nicolas Bovio, Michel Grzebyk et al.•International Journal of…•2022

  • Modes of Early Detection of Breast Cancer in Katowice Region, Poland

    Open Access•Jan Zejda, Jan Eugeniusz Zejda et al.•International Journal of…•2020

  • Chronic Obstructive Pulmonary Disease Increases the Risk of Mortality among Patients with Colorectal Cancer

    Open Access•Wei-Jen Cheng, Chih-Chao Chiang et al.•International Journal of…•2021

  • Comportements de santé et qualité de vie dans l’après-cancer

    Open Access•Pauline Jeanpierre, Amal Bernoussi et al.•Pratiques Psychologiques•2025

  • Refusal of treatment among HER2-positive breast cancer patients in China

    Open Access•Xin Wang, Zhiwei Lian et al.•Frontiers in Public Health•2024

  • Relationship between resilience, social support, and mental health in breast cancer patients based on the four-quadrant health model

    Open Access•Shuangrui Sui, Weicong Ma et al.•Frontiers in Public Health•2026

  • Disparities in Hepatocellular Carcinoma Survival by Insurance Status

    Open Access•Jing Wu, Chengyu Liu et al.•Frontiers in Public Health•2021

  • The shift of expenditure of medical service for diagnosis and treatment of colorectal cancer from 2005 to 2014

    Open Access•Wenjie Liang, Haiyan Lu et al.•Frontiers in Public Health•2025

  • Prostate Cancer Patterns and Trends in the Eastern Cape Province of South Africa; 1998–2017

    Open Access•Thendo Michael Ramaliba, Thendo Ramaliba et al.•Frontiers in Public Health•2022

  • Breast Cancer Survival in Eastern Region of Ghana

    Open Access•Paddy Ssentongo, John S Oh et al.•Frontiers in Public Health•2022

  • Multilayer framework for digital multicomponent platform design for colorectal survivors and carers

    Open Access•Samar J Melhem, Reem Kayyali•Frontiers in Public Health•2023

  • Grouping Together to Fight Cancer

    Open Access•Zhong Fangqi, Fangqi Zhong et al.•Frontiers in Public Health•2022

  • Disease burden and trends of malignant neoplasm of bone and articular cartilage in childhood in China, 1990–2021 and comparison with United States and India

    Open Access•Ruibo Li, Xingyue Yuan•Frontiers in Public Health•2025

  • Association Between Environmental and Socioeconomic Risk Factors and Hepatocellular Carcinoma

    Open Access•Wenfeng Lu, Fengjiao Zheng et al.•Frontiers in Public Health•2022

  • Global trends, decomposition analysis, inequality assessment, and economic projections of tracheal, bronchus, and lung cancer

    Open Access•Wenxuan Li, Yue Cong et al.•Frontiers in Public Health•2026

  • The systematic analysis and 10-year prediction on disease burden of childhood cancer in China

    Open Access•Bo Zhu, Xiaomei Wu et al.•Frontiers in Public Health•2022

  • Estimated five-year survival and direct healthcare costs of adult patients with gastric cancer

    Open Access•Uriel Palacios-Barahona, Fabio Olivella et al.•Frontiers in Public Health•2026

  • Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China

    Open Access•Hong Zhu, Jingmin Zhu et al.•Frontiers in Public Health•2022

  • Economic evaluation of anlotinib plus penpulimab vs. sorafenib as first-line therapy for unresectable hepatocellular carcinoma in China

    Open Access•Rui Fang, Jiajun Liang et al.•Frontiers in Public Health•2025

  • Optimized exercise prescription for alleviating cancer-related fatigue in breast cancer survivors after primary treatment

    Open Access•Zhonglin Dai, Yifan Zhang et al.•Frontiers in Public Health•2026

  • Spending and Hospital Stay for Melanoma in Hunan, China

    Open Access•Xinchen Ke, Wenrui Lin et al.•Frontiers in Public Health•2022

  • Global, regional, and national burden of children and adolescents with acute lymphoblastic leukemia from 1990 to 2021

    Open Access•Lei Wang, XUE YAO et al.•Frontiers in Public Health•2025

  • Nivolumab plus ipilimumab versus lenvatinib or sorafenib for US and Chinese patients with unresectable hepatocellular carcinoma

    Open Access•Qiuji Wu, Ying Qin et al.•Frontiers in Public Health•2026

  • Burden of kidney cancer and attributed risk factors in China from 1990 to 2019

    Open Access•Zongping Wang, Le Wang et al.•Frontiers in Public Health•2022

  • Prostate Cancer Incidence and Mortality

    Open Access•Le Wang, Bin Lu et al.•Frontiers in Public Health•2022

  • Worldwide patterns and trends in childhood and adolescent brain cancers, 1990–2021

    Open Access•Linbo Li, Chunhai Cai et al.•Frontiers in Public Health•2025

  • Gender differences, environmental pressures, tumor characteristics, and death rate in a lung cancer cohort

    Open Access•Antonia Mincuzzi, Simona Carone et al.•Frontiers in Public Health•2024

  • Smartphone sensors for evaluating Covid-19 fear in patients with cancer

    Open Access•Gabrielė Kasputytė, Gabrielė Jenciūtė et al.•Frontiers in Public Health•2024

  • Forecasting global progress in breast cancer control in the context of the sustainable development goals

    Open Access•Gizem S Nemutlu, Nathaniel D Mercaldo et al.•BMJ Global Health•2025

  • “In My Mind, It Was Just Temporary”

    Open Access•Corentin Montiel, Nathalie Bedrossian et al.•American Journal of Men s Health•2024

  • Mindfulness-based interventions for cancer patients in China

    Open Access•Zheng Zhang, Nurul Izzah Shari et al.•Current Psychology•2023

  • Structural brain changes and associated self-perceived cognitive deficits in chemotherapy-exposed patients with breast cancer

    Open Access•Wi Hoon Jung, Mison Chun et al.•Current Psychology•2024

  • Representatividad del Registro de Tumores Torácicos de España. Comparación de datos sociodemográficos con otros registros nacionales

    Open Access•Cristina Candal‐Pedreira, Alberto Ruano-Ravina et al.•Gaceta Sanitaria•2022

  • Exceso de mortalidad en las pacientes con cáncer de mama en estadios precoces en Tarragona y Gerona (España)

    Open Access•Ramón Clèries, Alberto Ameijide et al.•Gaceta Sanitaria•2020

  • Prospects for implementing the European Code of Cancer Practice

    Open Access•Joanna Kufel-Grabowska, Jacek Jassem•Health Policy•2026

  • Determinants of time to access to EMA-approved cancer drugs in Spanish NHS in the past decade

    Open Access•Pelayo Nieto-Gómez, Celia Castaño-Amores et al.•Health Policy•2025

  • The effects of exercise training for eight weeks on immune cell characteristics among breast cancer survivors

    Open Access•Ainhoa Arana Echarri, Lauren Struszczak et al.•Frontiers in Sports and Active…•2023

  • Assessing progress of India in reduction of premature mortality due to four noncommunicable diseases towards achieving the WHO 25×25 goal and the sustainable development goals

    Open Access•Vaitheeswaran Kulothungan, Thilagavathi Ramamoorthy et al.•Sustainable Development•2023

  • Emergence of social support networks among breast cancer survivors through a community-based physical activity program in Colombia

    Open Access•Martha Blanco, Ana María Guerra et al.•Social Networks•2023

  • YouTube as a source of information on clinical trials for paediatric cancer

    Open Access•Tove Godskesen, Sara Frygner Holm et al.•Information Communication & Society•2023

  • Breast cancer epidemiology and sociodemographic differences in BRICS-plus countries from 1990 to 2019

    Open Access•Sumaira Mubarik, Fang Wang et al.•SSM - Population Health•2023

  • Implementing and monitoring the right to health in breast cancer

    Open Access•Lisa Montel, Michel P Coleman et al.•International Journal for Equity…•2023

  • Socioeconomic inequalities in survival of children with acute lymphoblastic leukemia insured by social security in Mexico

    Open Access•Angélica Castro‐Ríos, Hortensia Reyes-Morales et al.•International Journal for Equity…•2019

  • The impact of sociodemographic factors on the utilization of radiation therapy in breast cancer patients in Estonia

    Open Access•Fereshteh Shahrabi Farahani, Keiu Paapsi et al.•International Journal for Equity…•2021

  • How the National Health Insurance Coverage policy changed the use of lenvatinib for adult patients with advanced hepatocellular carcinoma

    Open Access•Yanyan Liu, Yuwen Bao et al.•International Journal for Equity…•2023

  • The South African breast cancer and HIV outcomes study

    Open Access•Witness Mapanga, Oluwatosin A Ayeni et al.•PLOS Global Public Health•2023

  • Frequency and duration of suffering of cervical cancer patients and caregivers

    Open Access•Xiaoxiao Jiang Kwete, Khadidjatou Kane et al.•PLOS Global Public Health•2023

  • Towards attainment of the 2030 goal for childhood cancer survival for the World Health Organization Global Initiative for Childhood Cancer

    Open Access•E R Smith, Cesia Cotache-Condor et al.•PLOS Global Public Health•2024

  • The global burden of childhood and adolescent leukaemia and attributable risk factors

    Open Access•Yiran Cui, Yan Yan•Journal of Global Health•2024

  • Building capacity for cancer surveillance and public health research

    Open Access•Clarisse Joachim, Jacqueline Véronique-Baudin et al.•Journal of Global Health•2019

  • Survival of gastric cancer in China from 2000 to 2022

    Open Access•Houqiang Li, Han Zhang et al.•Journal of Global Health•2022

  • International cooperation in public health in Martinique

    Open Access•Clarisse Joachim, Thierry Almont et al.•Globalization and Health•2020

  • Global Surgery 2030

    Open Access•John G Meara, Andrew J M Leather et al.•The Lancet•2015

  • A scandal of invisibility

    Open Access•Philip Setel, Philip W Setel et al.•The Lancet•2007

  • Cancer incidence and mortality worldwide

    Open Access•J Ferlay, Isabelle Soerjomataram et al.•International Journal of Cancer•2015

  • Projections of the Cost of Cancer Care in the United States

    Angela B Mariotto, K Robin Yabroff et al.•CancerSpectrum Knowledge…•2011

  • Multivariable flexible modelling for estimating complete, smoothed life tables for sub-national populations

    Open Access•Bernard Rachet, Camille Maringe et al.•BMC Public Health•2015

  • A reducible four-parameter system of model life tables

    D C Ewbank, D Ewbank et al.•Population Studies•1983

Unique citing works128
Citations per year16
Citation span2018 - 2026 (9)
Citation velocitycurrent
Highly citedYes
Citation typesNeutral: 116
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae